Skip to main content
All lobbying clients

AQUESTIVE THERAPEUTICS

Lobbying client · Indiana · filed 2025 to 2026

pharmaceutical company

$340,000 Reported spend
9 Filings counted
2 Outside firms hired
2 Bills named

Spend is reported income plus in-house expenses across 9 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as AQUESTIVE THERAPEUTICS, INC.

 Who filed for this client 2

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 2
  • H.R. 1262
    Mikaela Naylon Give Kids a Chance Act
    3 filings
  • S. 932
    Give Kids a Chance Act of 2025
    3 filings
 Reported by year 2 years
  • 2026 $180,000 3 filings
  • 2025 $160,000 6 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 7
  • Consumer Product Safety Commission (CPSC) 5
  • HOUSE OF REPRESENTATIVES 5
  • SENATE 5
  • Food & Drug Administration (FDA) 4
  • Health & Human Services, Dept of (HHS) 4
  • Office of Management & Budget (OMB) 2
  • White House Office 2

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem